First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Johan Schultz et al.|Leukemia|2018Cited by 52
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profileShahryar Kiaii, Håkan Mellstedt, Parviz Kokhaei et al.|Cancer Immunology Immunotherapy|2012Cited by 23
Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic LeukemiaMohammad Hojjat‐Farsangi, Fazel Shokri, Mahmood Jeddi‐Tehrani et al.|PLoS ONE|2015Cited by 15
Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cellsParviz Kokhaei, Håkan Mellstedt, Mohammad Hojjat‐Farsangi et al.|PLoS ONE|2018Cited by 6
ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) CellsHåkan Mellstedt, Mohammad Hojjat‐Farsangi, Amineh Ghaderi et al.|Blood|2019Cited by 5